CpG Oligonucleotides Activate the Immune Response in Burned Mice

被引:1
|
作者
Yabuki, Teru [1 ]
Takeyama, Naoshi [2 ]
Tsuda, Masanobu [1 ]
Saitoh, Fukuki [1 ]
Tanaka, Takaya [3 ]
Noguchi, Hiroshi [2 ]
Nakatani, Toshio [1 ]
机构
[1] Kansai Med Univ, Dept Emergency & Crit Care Med, Osaka 5700074, Japan
[2] Aichi Med Univ, Dept Emergency & Crit Care Med, Aichi, Japan
[3] Handa City Hosp, Emergency Care Unit, Aichi, Japan
基金
日本学术振兴会;
关键词
burn injury; MHC class II expression; interleukin-12; interleukin-1; tumor necrosis factor-alpha; interleukin-6; immunoparalysis; CpG oligodeoxynucleotides; ESCHERICHIA-COLI INFECTIONS; COLONY-STIMULATING FACTOR; ANTIGEN-DR EXPRESSION; NECROSIS-FACTOR-ALPHA; INTERFERON-GAMMA; BACTERIAL-DNA; IFN-GAMMA; MACROPHAGES; PROTECTION; RESISTANCE;
D O I
10.1016/j.jss.2009.01.033
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Immunosuppression after burn injury increases the risk of sepsis and multiple organ failure. We examined changes of immune function in mice after burn injury and investigated the immunostimulatory effect of oligodeoxynucleotides containing CpG motifs. Materials and Methods. Male BALB/c mice (8-10 wk old) received a full-thickness burn to 20% of their body surface area, after which the immunological parameters of splenic macrophages were evaluated. To assess the immunostimulatory effect of oligodeoxynucleotide treatment, splenic macrophages harvested from burned mice were incubated with oligodeoxynucleotides. Then cytokine production and major histocompatibility complex class H antigen expression were measured. To assess the in vivo effect of oligodeoxynucleotides, intraperitoneal administration was done on day 4 after burn injury, and class II antigen expression by splenic macrophages was measured 10 d later. Results. Class II antigen expression and the synthesis of cytokines (interleukin-12, tumor necrosis factor-alpha, interleukin-6, and interleukin-1) by splenic macrophages were significantly reduced after burn injury, while incubation of splenic macrophages from burned mice with oligodeoxynucleotides partially enhanced the production of interleukin-12, tumor necrosis factor-a, interleukin-6, and interleukin-1. In addition, intraperitoneal administration of oligodeoxynucleotides enhanced class II antigen expression by splenic macrophages. Conclusions. The reduction of class II antigen expression and synthesis of cytokines (interleukin-12, tumor necrosis factor-a, interleukin-6, and interleukin-1) by splenic macrophages after burn injury was partially reversed by oligodeoxynucleotide treatment. Therefore, immunostimulatory oligodeoxynucleotides may be a potential treatment for post-burn immunosuppression. (C) 2010 Elsevier Inc. All rights reserved
引用
收藏
页码:111 / 118
页数:8
相关论文
共 50 条
  • [41] CPG OLIGONUCLEOTIDES REGULATE THE DIFFERENTIATION OF OSTEOCLAST
    张志刚
    赵为公
    刘淼
    李曙明
    Academic Journal of Xi'an Jiaotong University, 2004, (02) : 160 - 163
  • [42] Immunotherapeutic Potential of CpG Oligonucleotides in Chickens
    Dar, Arshud
    Allan, Brenda
    Gomis, Susantha
    Potter, Andrew
    Mutwiri, George
    JOURNAL OF POULTRY SCIENCE, 2009, 46 (02): : 69 - 80
  • [43] Neonate Intestinal Immune Response to CpG Oligodeoxynucleotide Stimulation
    Lacroix-Lamande, Sonia
    Rochereau, Nicolas
    Mancassola, Roselyne
    Barrier, Mathieu
    Clauzon, Amandine
    Laurent, Fabrice
    PLOS ONE, 2009, 4 (12):
  • [44] Recent advances in immunostimulatory CpG oligonucleotides
    Rothenfusser, S
    Tuma, E
    Wagner, M
    Endres, S
    Hartmann, G
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (02) : 98 - 106
  • [45] Differential Cytokine Production and Bystander Activation of Autoreactive B Cells in Response to CpG-A and CpG-B Oligonucleotides
    Avalos, Ana M.
    Latz, Eicke
    Mousseau, Betty
    Christensen, Sean R.
    Shlomchik, Mark J.
    Lund, Frances
    Marshak-Rothstein, Ann
    JOURNAL OF IMMUNOLOGY, 2009, 183 (10): : 6262 - 6268
  • [46] CpG Oligonucleotides as Cancer Vaccine Adjuvants
    Shirota, Hidekazu
    Tross, Debra
    Klinman, Dennis M.
    VACCINES, 2015, 3 (02) : 390 - 407
  • [47] CPG OLIGONUCLEOTIDES REGULATE OSTEOCLAST DIFFERENTIATION
    赵为公
    韩学哲
    李新友
    郭雄
    刘淼
    Academic Journal of Xi'an Jiaotong University, 2005, (01) : 90 - 93
  • [48] CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma
    Miles, Suzanne A.
    Sandler, Anthony D.
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (03) : 275 - 282
  • [49] Optically triggered immune response through photocaged oligonucleotides
    Govan, Jeane M.
    Young, Douglas D.
    Lively, Mark O.
    Deiters, Alexander
    TETRAHEDRON LETTERS, 2015, 56 (23) : 3639 - 3642
  • [50] Non-CpG-containing antisense 2′-methoxyethyl oligonucleotides activate a proinflammatory response independent of toll-like receptor 9 or myeloid differentiation factor 88
    Senn, JJ
    Burel, S
    Henry, SP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (03): : 972 - 979